Biochemical studies for the diagnosis of porphyrias

Authors

  • Marta Capilla Díez Specialist in Clinical Analysis. Clinical Analysis Service. Río Hortega University Hospital, Valladolid, Spain https://orcid.org/0009-0002-5292-1998
  • Patricia Ramos Mayordomo Resident Pharmacist. Clinical Analysis Service. Río Hortega University Hospital, Valladolid, Spain. https://orcid.org/0009-0009-5447-3384

DOI:

https://doi.org/10.24197/ncqq5730

Keywords:

porphyrins, porphobilinogen, Hoesch, urine, biochemistry

Abstract

Porphyrias are a group of metabolic disorders, either acquired or hereditary, caused by enzymatic deficiencies in the heme biosynthesis pathway, which originates from the precursors glycine and succinyl-CoA. Acquired forms may result from triggering factors such as iron overload, liver diseases, cytochrome P450-inducing drugs, smoking, or alcohol consumption. Depending on the specific enzymatic defect within the metabolic pathway, there is an accumulation of various heme precursors, such as delta-aminolevulinic acid, porphobilinogen and different types of porphyrins (uroporphyrins, coproporphyrins, and protoporphyrins). Porphyrias are classified according to the tissue in which the metabolic defect predominates into hepatic or erythropoietic forms, and based on clinical presentation into acute, cutaneous, or mixed types. Diagnosis relies on the assessment of clinical symptoms and the performance of biochemical and genetic studies, with biochemical studies being essential for confirming and accurately classifying the type of porphyria.

Downloads

Download data is not yet available.

References

Uriarte Mayorga DF, Gómez González BA, Mancinelli MC, Candelo Viafara PA. Porfirias: una revisión. Dermatología CMQ 2021;19(4):361-367.

Longarón Arribas E, Florido Harana I, Gan García R, Urcia Juberias Y, Martín Melendo A, Martín Pérez N. Las porfirias agudas y su diagnóstico en el laboratorio. Revista Sanitaria de Investigación 2021; 2(5).

Castelbón Fernández FJ, Solares Fernandez I, Arranz Canales E, Enríquez de Salamanca Lorente R, Morales Conejo M. Protocol For Patients With Suspected Acute Porphyria. Rev Clin Esp. 2020 Dec;220(9):592-596.

Santamaría González M., Arruebo Muñío M. Porfiria aguda intermitente. Educación continuada en el Laboratorio Clínico SEQC. Ed Cont Lab Clín 2016;27:66-76.

Servicio Andaluz de Salud. Guía asistencial de porfirias. En: Plan de atención a personas afectadas por enfermedades raras de Andalucía. Sevilla: Servicio Andaluz de Salud; 2011.

To Figueras J. Porfirias. Educación Continuada en el Laboratorio Clínico SEQC. Ed Cont Lab Clín 2007;11:1-8.

Downloads

Published

2025-10-23

Issue

Section

Imágenes/Infografías